Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prescription Sleep Aids
1.2.3 Over-the-Counter Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Homecare
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Pharmacological Treatment Market Perspective (2017-2028)
2.2 Insomnia Pharmacological Treatment Growth Trends by Region
2.2.1 Insomnia Pharmacological Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Insomnia Pharmacological Treatment Historic Market Size by Region (2017-2022)
2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Region (2023-2028)
2.3 Insomnia Pharmacological Treatment Market Dynamics
2.3.1 Insomnia Pharmacological Treatment Industry Trends
2.3.2 Insomnia Pharmacological Treatment Market Drivers
2.3.3 Insomnia Pharmacological Treatment Market Challenges
2.3.4 Insomnia Pharmacological Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Pharmacological Treatment Players by Revenue
3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2017-2022)
3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
3.4 Global Insomnia Pharmacological Treatment Market Concentration Ratio
3.4.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2021
3.5 Insomnia Pharmacological Treatment Key Players Head office and Area Served
3.6 Key Players Insomnia Pharmacological Treatment Product Solution and Service
3.7 Date of Enter into Insomnia Pharmacological Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Pharmacological Treatment Breakdown Data by Type
4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2017-2022)
4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2023-2028)
5 Insomnia Pharmacological Treatment Breakdown Data by Application
5.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2017-2022)
5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Insomnia Pharmacological Treatment Market Size (2017-2028)
6.2 North America Insomnia Pharmacological Treatment Market Size by Type
6.2.1 North America Insomnia Pharmacological Treatment Market Size by Type (2017-2022)
6.2.2 North America Insomnia Pharmacological Treatment Market Size by Type (2023-2028)
6.2.3 North America Insomnia Pharmacological Treatment Market Share by Type (2017-2028)
6.3 North America Insomnia Pharmacological Treatment Market Size by Application
6.3.1 North America Insomnia Pharmacological Treatment Market Size by Application (2017-2022)
6.3.2 North America Insomnia Pharmacological Treatment Market Size by Application (2023-2028)
6.3.3 North America Insomnia Pharmacological Treatment Market Share by Application (2017-2028)
6.4 North America Insomnia Pharmacological Treatment Market Size by Country
6.4.1 North America Insomnia Pharmacological Treatment Market Size by Country (2017-2022)
6.4.2 North America Insomnia Pharmacological Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Insomnia Pharmacological Treatment Market Size (2017-2028)
7.2 Europe Insomnia Pharmacological Treatment Market Size by Type
7.2.1 Europe Insomnia Pharmacological Treatment Market Size by Type (2017-2022)
7.2.2 Europe Insomnia Pharmacological Treatment Market Size by Type (2023-2028)
7.2.3 Europe Insomnia Pharmacological Treatment Market Share by Type (2017-2028)
7.3 Europe Insomnia Pharmacological Treatment Market Size by Application
7.3.1 Europe Insomnia Pharmacological Treatment Market Size by Application (2017-2022)
7.3.2 Europe Insomnia Pharmacological Treatment Market Size by Application (2023-2028)
7.3.3 Europe Insomnia Pharmacological Treatment Market Share by Application (2017-2028)
7.4 Europe Insomnia Pharmacological Treatment Market Size by Country
7.4.1 Europe Insomnia Pharmacological Treatment Market Size by Country (2017-2022)
7.4.2 Europe Insomnia Pharmacological Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size (2017-2028)
8.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type
8.2.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Insomnia Pharmacological Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application
8.3.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Insomnia Pharmacological Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region
8.4.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Insomnia Pharmacological Treatment Market Size (2017-2028)
9.2 Latin America Insomnia Pharmacological Treatment Market Size by Type
9.2.1 Latin America Insomnia Pharmacological Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Insomnia Pharmacological Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Insomnia Pharmacological Treatment Market Share by Type (2017-2028)
9.3 Latin America Insomnia Pharmacological Treatment Market Size by Application
9.3.1 Latin America Insomnia Pharmacological Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Insomnia Pharmacological Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Insomnia Pharmacological Treatment Market Share by Application (2017-2028)
9.4 Latin America Insomnia Pharmacological Treatment Market Size by Country
9.4.1 Latin America Insomnia Pharmacological Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Insomnia Pharmacological Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size (2017-2028)
10.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type
10.2.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Insomnia Pharmacological Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application
10.3.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Insomnia Pharmacological Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country
10.4.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Details
11.1.2 Eisai, Co. Ltd. (Japan) Business Overview
11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.1.5 Eisai, Co. Ltd. (Japan) Recent Developments
11.2 Merck & Co., Inc (US)
11.2.1 Merck & Co., Inc (US) Company Details
11.2.2 Merck & Co., Inc (US) Business Overview
11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Introduction
11.2.4 Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.2.5 Merck & Co., Inc (US) Recent Developments
11.3 Meda Consumer Healthcare Inc (US)
11.3.1 Meda Consumer Healthcare Inc (US) Company Details
11.3.2 Meda Consumer Healthcare Inc (US) Business Overview
11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Introduction
11.3.4 Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.3.5 Meda Consumer Healthcare Inc (US) Recent Developments
11.4 Pfizer, Inc (US)
11.4.1 Pfizer, Inc (US) Company Details
11.4.2 Pfizer, Inc (US) Business Overview
11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Introduction
11.4.4 Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.4.5 Pfizer, Inc (US) Recent Developments
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Details
11.5.2 Sanofi (France) Business Overview
11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction
11.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.5.5 Sanofi (France) Recent Developments
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Developments
11.7 Pernix Therapeutics (US)
11.7.1 Pernix Therapeutics (US) Company Details
11.7.2 Pernix Therapeutics (US) Business Overview
11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Introduction
11.7.4 Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.7.5 Pernix Therapeutics (US) Recent Developments
11.8 Purdue Pharma L.P (US)
11.8.1 Purdue Pharma L.P (US) Company Details
11.8.2 Purdue Pharma L.P (US) Business Overview
11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Introduction
11.8.4 Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2017-2022)
11.8.5 Purdue Pharma L.P (US) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer